Your browser doesn't support javascript.
loading
Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua.
Nair, Nisha; De Wolf, Dries; Nguyen, Phuong Anh; Pham, Quang Hong; Samara-Kuko, Ermira; Landau, Jeff; Blouse, Grant E; Chuah, Marinee K; VandenDriessche, Thierry.
Afiliação
  • Nair N; Department of Gene Therapy and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
  • De Wolf D; Department of Gene Therapy and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
  • Nguyen PA; Department of Gene Therapy and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
  • Pham QH; Department of Gene Therapy and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
  • Samara-Kuko E; Department of Gene Therapy and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
  • Landau J; Catalyst Biosciences, South San Francisco, CA; and.
  • Blouse GE; Catalyst Biosciences, South San Francisco, CA; and.
  • Chuah MK; Department of Gene Therapy and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
  • VandenDriessche T; Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium.
Blood ; 137(21): 2902-2906, 2021 05 27.
Article em En | MEDLINE | ID: mdl-33735915
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Hemofilia B Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Hemofilia B Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica